CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
CBAT
CBAK Energy Technology, Inc.
There isn't enough reported data to score CBAT yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CBAT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Strong | |
| Weak |
CBAT's revenue and cash flow are currently strong, but its profitability and balance sheet are weak.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
CBAT PE Valuation
CBAT has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 4.8x next year's earnings.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CBAT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect CBAT to return to profit, with revenue growing.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
CBAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.20 | — |
| Q1 2026 | -$0.18 | -$0.18 |
| Q4 2025 | -$0.10 | -177% |
| Q3 2025 | -$0.07 | -154% |
| Q2 2025 | -$0.10 | -150% |
| Q1 2025 | $0.00 | -100% |
| Q4 2024 | $0.13 | +$0.16 |
| Q3 2024 | $0.13 | +$0.23 |
| Q2 2024 | $0.20 | +$0.37 |
CBAT is still losing money, but less than at its worst: $0.18 per share over the past year, against $0.35 at its worst in late 2019.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CBAT has the stronger quarterly revenue trend. Revenue is up 17% for CAT versus up 99% for CBAT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
CBAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.6M | +99% |
| Q4 2025 | $58.8M | +132% |
| Q3 2025 | $60.9M | +37% |
| Q2 2025 | $40.5M | -15% |
| Q1 2025 | $34.9M | -41% |
| Q4 2024 | $25.4M | -55% |
| Q3 2024 | $44.6M | -30% |
| Q2 2024 | $47.8M | +13% |
CBAT's revenue is growing: $70M last quarter, up 99% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -14% | -5.7 points |
| Q4 2025 | -14% | +12 points |
| Q3 2025 | -6.6% | -4.8 points |
| Q2 2025 | -8.7% | -21 points |
| Q1 2025 | -8.2% | -26 points |
| Q4 2024 | -26% | -16 points |
| Q3 2024 | -1.9% | -10 points |
| Q2 2024 | 12% | +21 points |
CBAT's operating margin was −14% last quarter, down 5.7 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CBAT has the stronger cash trend. Its trailing FCF is up 6,165% versus its history, compared with CAT at up 39%.
CBAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | $10.5M | +$32.8M |
| Q4 2025 | $16.1M | +310% |
| Q3 2025 | $6M | -64% |
| Q2 2025 | $4.1M | +65% |
| Q1 2025 | -$22.3M | -$21.9M |
| Q4 2024 | $3.9M | -80% |
| Q3 2024 | $16.5M | +$17M |
| Q1 2024 | -$454K | -105% |
CBAT generated $37M in free cash flow over the past year, more than ten times what it generated the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over CBAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CBAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.8% | -692K shares |
| 3 years | +0.3% | +234K shares |
| 5 years | +5.1% | +4.3M shares |
| Available history | +152% | +53.9M shares |
CBAT has 89M diluted shares, down 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | $263,111 |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
CBAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 8.4x | High |
| Q4 2024 | 3.6x | Elevated |
| Q3 2024 | 2.9x | Moderate |
| Q2 2024 | -0.3x | Net Cash |
| Q1 2024 | 1.2x | Healthy |
| Q4 2023 | -1.8x | Net Cash |
CBAT's net debt is about 8.4 years of its operating earnings (EBITDA), up from 1.2 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CBAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 48.3 | Neutral |
CBAT's weekly RSI is 52 (neutral) and its Stochastic is 48 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CBAT PE vs Industrials Sector
| Metric | CBAT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
CBAT has no meaningful PE right now: it lost money over the past year.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
CBAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.08 | 11% below |
| 20 week MA | $0.88 | 9.1% above |
| 50 week MA | $0.85 | 13% above |
| 100 week MA | $0.89 | 7.9% above |
| 200 week MA | $0.97 | 1% below |
CBAT has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
CBAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.14 | $6.26 | +449% |
| 2021 | $6.26 | $1.69 | -73% |
| 2022 | $1.69 | $0.98 | -42% |
| 2023 | $0.98 | $1.05 | +7.1% |
| 2024 | $1.05 | $1.07 | +1.9% |
| 2025 | $1.07 | $0.86 | -20% |
| 2026 YTD | $0.86 | $0.96 | +12% |
CBAT has the edge over CAT on returns for 2026, with the stronger performance.